MedTrace Logo

Injectable Platelet Rich Fibrin With Collagen Matrix in Treatment of Multiple Gingival Recession.

NCT05389059 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-05-24

No results posted yet for this study

Summary

This study is proposing the use of i-PRF clot as a scaffold for the XCM in order to obtain a novel biomaterial, incorporating active growth factors and collagen matrix in a single framework, based on the potential effect of i-PRF to enhance fibroblast activity and angiogenesis stimulation for treatment of multiple gingival recession.

Conditions

  • Gingival Diseases
  • Traumatic Injury

Interventions

PROCEDURE

CAF+CM

Periodontal surgery including CAF+CM application

PROCEDURE

I-PRF

Periodontal surgery including CAF+CM application with i-PRF

Sponsors & Collaborators

  • University of Baghdad

    lead OTHER

Principal Investigators

  • Basima Gh Ali, MSc · University of Baghdad

  • Thair AL Hassan, PHD · University of Baghdad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-25
Primary Completion
2023-03-30
Completion
2023-09-01

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05389059 on ClinicalTrials.gov